2922 related articles for article (PubMed ID: 7688498)
21. Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival.
Kawada K; Kawano T; Nagai K; Nishikage T; Nakajima Y; Tokairin Y; Ogiya K; Tanaka K; Iwai T
Gastrointest Endosc; 2007 Aug; 66(2):408-10. PubMed ID: 17643724
[No Abstract] [Full Text] [Related]
22. [Malignant melanoma of the alimentary tract].
Nakamura T; Ide H
Gan To Kagaku Ryoho; 2003 May; 30(5):619-25. PubMed ID: 12795092
[TBL] [Abstract][Full Text] [Related]
23. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
Kretschmer L; Helmbold P; Emmert S; Marsch WC
Hautarzt; 2002 Aug; 53(8):536-41. PubMed ID: 12221468
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of metastasized malignant melanoma].
Kamanabrou D
Praxis (Bern 1994); 2001 Mar; 90(10):391-6. PubMed ID: 11305184
[TBL] [Abstract][Full Text] [Related]
25. Complex combination biochemotherapy regimen in advanced metastatic melanoma in a non-intensive care unit: toxicity or benefit?
Hofmann MA; Sterry W; Trefzer U
Jpn J Clin Oncol; 2007 Mar; 37(3):224-9. PubMed ID: 17472972
[TBL] [Abstract][Full Text] [Related]
26. The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
McClay EF; McClay ME; Monroe L; Baron PL; Cole DJ; O'Brien PH; Metcalf JS; Maize JC
Br J Cancer; 2000 Jul; 83(1):16-21. PubMed ID: 10883662
[TBL] [Abstract][Full Text] [Related]
27. [Chemotherapy in disseminated malignant skin melanoma with a combination of nitrosomethylurea, vincristine, peplomycin or bleomycetin].
Tanaev VG; Gershanovich MA
Vopr Onkol; 1991; 37(2):162-7. PubMed ID: 1707570
[TBL] [Abstract][Full Text] [Related]
28. [Primary malignant melanoma of the female urethra: a case report].
Kajikawa H; Takada M; Seguchi T; Sakaguchi H
Hinyokika Kiyo; 1987 Jan; 33(1):97-100. PubMed ID: 2437781
[TBL] [Abstract][Full Text] [Related]
29. Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma.
Ott PA; Chang JL; Oratz R; Jones A; Farrell K; Muggia F; Pavlick AC
Chemotherapy; 2009; 55(4):221-7. PubMed ID: 19451711
[TBL] [Abstract][Full Text] [Related]
30. Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.
Lewis KD; Robinson WA; McCarter M; Pearlman N; O'Day SJ; Anderson C; Amatruda TT; Baron A; Zeng C; Becker M; Dollarhide S; Matijevich K; Gonzalez R
J Clin Oncol; 2006 Jul; 24(19):3157-63. PubMed ID: 16809738
[TBL] [Abstract][Full Text] [Related]
31. Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma.
Richman SP; Woodcock TM; Kubota TT; Blumenreich MS; Gentile PS; Allegra JC
Cancer Treat Rep; 1984 Nov; 68(11):1395-6. PubMed ID: 6209008
[No Abstract] [Full Text] [Related]
32. Bleomycin, carmustine, vincristine, and dacarbazine in patients with metastatic malignant melanoma.
Cohen SM; Ohnuma T; Cheung T; Holland JF
Cancer Treat Rep; 1983 Oct; 67(10):947-8. PubMed ID: 6194881
[No Abstract] [Full Text] [Related]
33. Therapy-related myelodysplastic syndrome developed by dacarbazine, nimustine hydrochloride and vincristine sulfate (DAV) therapy for patient with malignant melanoma.
Nitta Y; Ikeya T; Sakakibara A; Tomita Y
J Dermatol; 2011 Feb; 38(2):164-8. PubMed ID: 21269313
[TBL] [Abstract][Full Text] [Related]
34. Treatment and prognosis of malignant melanoma of the oral cavity: preoperative surgical procedure increases risk of distant metastasis.
Umeda M; Komatsubara H; Shigeta T; Ojima Y; Minamikawa T; Shibuya Y; Yokoo S; Komori T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):51-7. PubMed ID: 18504155
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic response of interferon-beta in malignant melanoma].
Ishihara K
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1010-6. PubMed ID: 2421645
[TBL] [Abstract][Full Text] [Related]
36. Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy.
Legha SS
Semin Oncol; 1997 Feb; 24(1 Suppl 4):S39-43. PubMed ID: 9122733
[TBL] [Abstract][Full Text] [Related]
37. Dacarbazine, nimustine hydrochloride, cisplatin and tamoxifen combination chemotherapy for advanced malignant melanoma.
Yamazaki N; Yamamoto A; Wada T; Ishikawa M
J Dermatol; 1999 Aug; 26(8):489-93. PubMed ID: 10487002
[TBL] [Abstract][Full Text] [Related]
38. A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma.
Middleton MR; Lorigan P; Owen J; Ashcroft L; Lee SM; Harper P; Thatcher N
Br J Cancer; 2000 Mar; 82(6):1158-62. PubMed ID: 10735499
[TBL] [Abstract][Full Text] [Related]
39. New approaches to the chemotherapy of melanoma.
Glover DJ
Oncology (Williston Park); 1991 May; 5(5):95-8; discussion 101-2, 104. PubMed ID: 1715735
[TBL] [Abstract][Full Text] [Related]
40. Lomustine, bleomycin, and cisplatin in patients with metastatic malignant melanoma.
Cohen SM; Ohnuma T; Ambinder EP; Holland JF
Cancer Treat Rep; 1986 May; 70(5):688-9. PubMed ID: 2423239
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]